Literature DB >> 10982372

Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence.

H Ebihara1, K Yoshimatsu, M Ogino, K Araki, Y Ami, H Kariwa, I Takashima, D Li, J Arikawa.   

Abstract

Two Hantaan virus strains, clone 1 (cl-1), which is virulent in newborn mice, and its attenuated mutant (mu11E10), were used to examine the pathogenesis of Hantaan virus infection in a mouse model and identify virus factors relating to virulence. After subcutaneous inoculation of newborn BALB/c mice, cl-1 caused fatal disease with high viral multiplication in peripheral organs, but mu11E10 produced nonfatal infection with a low level of virus multiplication. Intracerebral inoculation of either strain caused fatal disease. Histopathological changes in the dead animals were prominent in the brain, indicating that the brain is the target organ and produces the fatal outcome. These results indicate that mu11E10 has a generally less virulent phenotype, and because of decreased multiplication in peripheral tissues, neuroinvasiveness is also decreased. An experiment with genetic reassortant viruses showed that in newborn mice the M segment is the most related to virulence and the L segment is partly related. Sequence comparison detected a single deduced amino acid change (cl-1 Ile to mu11E10 Thr) at amino acid number 515 in glycoprotein G1. One nucleotide change, but no amino acid substitution, was observed in the noncoding region of the L segment. In mouse brain microvascular endothelial cells in vitro, viruses possessing a cl-1-derived M segment grew more rapidly than viruses containing a mu11E10-derived M segment. These results suggest that the single amino acid change in the glycoprotein alters peripheral growth, which affects invasion of the central nervous system in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982372      PMCID: PMC102124          DOI: 10.1128/jvi.74.19.9245-9255.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.

Authors:  P Vialat; A Billecocq; A Kohl; M Bouloy
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.

Authors:  M J Endres; C Griot; F Gonzalez-Scarano; N Nathanson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  N-acetylgalactosamine (GalNAc)-specific lectins mediate enhancement of Hantaan virus infection.

Authors:  M Ogino; K Yoshimatsu; H Ebihara; J Arikawa
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

4.  Studies on immunopathogenesis in epidemic hemorrhagic fever: sequential observations on activation of the first complement component in sera from patients with epidemic hemorrhagic fever.

Authors:  D Yan; X Gu; D Wang; S Yang
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

5.  Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome.

Authors:  C S Schmaljohn; S E Hasty; S A Harrison; J M Dalrymple
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

6.  Identification of a putative alphavirus receptor on mouse neural cells.

Authors:  S Ubol; D E Griffin
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  CNS manifestations of epidemic hemorrhagic fever. An advanced manifestation of disease associated with poor prognosis.

Authors:  M S Cohen; H E Kwei; C C Chin; H C Ge
Journal:  Arch Intern Med       Date:  1983-11

8.  Immunofluorescence studies of disseminated Hantaan virus infection of suckling mice.

Authors:  T Kurata; T F Tsai; S P Bauer; J B McCormick
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice.

Authors:  T Nakamura; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

10.  Pathogenesis of Hantaan virus infection in suckling mice: clinical, virologic, and serologic observations.

Authors:  G R Kim; K T McKee
Journal:  Am J Trop Med Hyg       Date:  1985-03       Impact factor: 2.345

View more
  30 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

2.  Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains.

Authors:  Sina Kirsanovs; Boris Klempa; Renate Franke; Min-Hi Lee; Günther Schönrich; Andreas Rang; Detlev H Kruger
Journal:  Virus Genes       Date:  2010-08-24       Impact factor: 2.332

3.  Thrips and tospoviruses come of age: mapping determinants of insect transmission.

Authors:  Diane E Ullman; Anna E Whitfield; Thomas L German
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

4.  Saaremaa hantavirus should not be confused with its dangerous relative, Dobrava virus.

Authors:  Alexander Plyusnin; Antti Vaheri; Ake Lundkvist
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.

Authors:  Yoshimi Tsuda; Thomas Hoenen; Logan Banadyga; Carla Weisend; Stacy M Ricklefs; Stephen F Porcella; Hideki Ebihara
Journal:  J Infect Dis       Date:  2015-03-24       Impact factor: 5.226

6.  Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection.

Authors:  Yoshimi Tsuda; David Safronetz; Kyle Brown; Rachel LaCasse; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

7.  Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells.

Authors:  Jae-Hwan Nam; Kyung-A Hwang; Cheong-Hee Yu; Tae-Hoon Kang; Jae-Young Shin; Woo-Young Choi; In-Beom Kim; Young-Ran Joo; Hae-Wol Cho; Keun-Yong Park
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

8.  A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.

Authors:  Igor S Lukashevich; Jean Patterson; Ricardo Carrion; Dmitry Moshkoff; Anysha Ticer; Juan Zapata; Kathleen Brasky; Robert Geiger; Gene B Hubbard; Joseph Bryant; Maria S Salvato
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Hantavirus-specific CD8(+)-T-cell responses in newborn mice persistently infected with Hantaan virus.

Authors:  Koichi Araki; Kumiko Yoshimatsu; Byoung-Hee Lee; Hiroaki Kariwa; Ikuo Takashima; Jiro Arikawa
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Adaptation of Puumala hantavirus to cell culture is associated with point mutations in the coding region of the L segment and in the noncoding regions of the S segment.

Authors:  Kirill Nemirov; Ake Lundkvist; Antti Vaheri; Alexander Plyusnin
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.